Ciclosporin Eye Drops — $300 Instead of $700+
Compare pricing, options, and buy alternatives to Restasis — including Vevizye.
If you've been prescribed ciclosporin eye drops in the US, you've likely seen prices of $600–$800 per month. The same category of treatment is available for $300.
View Price & Availability
Why Are You Paying $700 for Eye Drops?
US pricing for ophthalmic solutions is often inflated by multiple layers of distribution, insurance negotiations, and administrative costs.
The Distribution Gap
Traditional US pharmacies add significant markups to cover complex insurance billing cycles. When you purchase direct through specialized clinical channels, these markups vanish.
“The medication class is exactly the same — the price difference comes from distribution.”
-$400
Average Monthly Savings
By bypassing the standard US distribution model, we offer the same clinical efficacy at a fraction of the legacy pharmacy price.
Ophthalmic Treatment
What Are Ciclosporin Eye Drops?
A targeted immunosuppressant treatment designed to restore your eyes' natural tear production.
Inflammation Control
Ciclosporin is a calcineurin inhibitor immunosuppressant that specifically targets chronic inflammation in the tear glands.
Natural Tear Production
By reducing inflammation, the drops help your eyes regain their natural ability to produce tears, providing long-term relief rather than temporary moisture.
Precision Solution
Vevizye is a clear ophthalmic solution, designed for consistent dosing and high ocular bioavailability.
Available for $300
Clinical grade treatment, delivered to your door.
Vevizye (Ciclosporin Ophthalmic Solution)
0.1% Ciclosporin Weight/Volume
No insurance required • No hidden fees
- Equivalent active ingredient to Restasis
- High-purity ophthalmic solution
- 30-day treatment duration per bottle
Why Is It $300 Instead of $700?
The difference comes down to how the product reaches you:
- No US pharmacy markups
- Different international pricing structures
- Direct supply model from EU regulated pharamcies.
"You are not paying for the US pricing system — just the product itself."
Restasis VS Vevizye
See how our product measures up against the leading brand.
| Feature |
|
|
|---|---|---|
| Active Ingredient | Active Ingredient Ciclosporin 0.05% | Active Ingredient Ciclosporin 0.1% |
| Type | Type Emulsion | Type Solution (Clear) |
| Price | Price $600 - $800+ | Price $300 |
| Access | Access US Local Pharmacy | Access Direct Purchase |
What to Expect
Understanding the journey to ocular comfort is key to successful treatment.
Gradual Onset
Full clinical benefits typically manifest between 4 to 12 weeks of consistent use. This is not a "quick fix" but a structural treatment.
Initial Sensation
A mild stinging or burning sensation upon application is common and usually subsides as your eyes adjust to the formula.
Consistency is Key
For maximum efficacy, drops must be applied twice daily (every 12 hours) exactly as prescribed by your ophthalmologist.
Long-term Safety
Ciclosporin has a well-established safety profile for long-term chronic use in patients with keratoconjunctivitis sicca.
Frequently Asked Questions
Is Vevizye the same as Restasis?
Both use ciclosporin, but differ in formulation and delivery.
Why is the price so different?
Pricing depends heavily on distribution, pharmacy systems, and location.
Is this genuine medication?
Yes — products are sourced from regulated suppliers, the European equivalent to the FDA.
Why is Restasis more expensive?
US pricing structures and pharmacy markups significantly increase cost, as with many US pharmaceutical products.
Who is this suitable for?
Patients with moderate to severe chronic dry eye.
Stop Paying $700 for the Same Category of Treatment
Take control of your eye health without financial burden of US pharmacy markups.
